Morgan Stanley’s Relay Therapeutics RLAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.2M Sell
1,432,003
-586,461
-29% -$5.25M ﹤0.01% 3265
2025
Q4
$17.1M Buy
2,018,464
+254,368
+14% +$1.82M ﹤0.01% 3079
2025
Q3
$9.21M Buy
1,764,096
+341,750
+24% +$1.3M ﹤0.01% 3616
2025
Q2
$4.92M Sell
1,422,346
-170,840
-11% -$508K ﹤0.01% 4076
2025
Q1
$4.17M Buy
1,593,186
+292,416
+22% +$1.15M ﹤0.01% 4077
2024
Q4
$5.36M Buy
1,300,770
+338,659
+35% +$1.84M ﹤0.01% 3930
2024
Q3
$6.81M Sell
962,111
-280,167
-23% -$2.09M ﹤0.01% 3711
2024
Q2
$8.1M Buy
1,242,278
+85,257
+7% +$583K ﹤0.01% 3475
2024
Q1
$9.6M Sell
1,157,021
-300,387
-21% -$2.93M ﹤0.01% 3381
2023
Q4
$16M Buy
1,457,408
+799,867
+122% +$6.75M ﹤0.01% 3534
2023
Q3
$5.53M Sell
657,541
-119,926
-15% -$1.29M ﹤0.01% 3663
2023
Q2
$9.76M Buy
777,467
+215,333
+38% +$2.68M ﹤0.01% 3187
2023
Q1
$9.26M Sell
562,134
-1,807,210
-76% -$32.4M ﹤0.01% 3219
2022
Q4
$35.4M Buy
2,369,344
+2,027,003
+592% +$38.8M ﹤0.01% 1805
2022
Q3
$7.66M Sell
342,341
-283,783
-45% -$6.23M ﹤0.01% 3250
2022
Q2
$10.5M Buy
626,124
+194,644
+45% +$4.17M ﹤0.01% 3023
2022
Q1
$12.9M Sell
431,480
-92,013
-18% -$2.23M ﹤0.01% 2597
2021
Q4
$16.1M Buy
523,493
+76,702
+17% +$2.42M ﹤0.01% 2399
2021
Q3
$14.1M Sell
446,791
-122,854
-22% -$4.14M ﹤0.01% 2499
2021
Q2
$20.8M Buy
569,645
+79,037
+16% +$2.6M ﹤0.01% 2106
2021
Q1
$17M Buy
490,608
+361,849
+281% +$15.7M ﹤0.01% 2089
2020
Q4
$5.35M Buy
128,759
+24,434
+23% +$1.1M ﹤0.01% 3185
2020
Q3
$4.44M Buy
+104,325
New +$3.98M ﹤0.01% 2826

Other funds holding RLAY